179 related articles for article (PubMed ID: 28665037)
1. Prevalence of potentially serious drug-drug interactions among South African elderly private health sector patients using the Mimica Matanović/Vlahović-Palčevski protocol.
van Heerden JA; Burger JR; Gerber JJ; Vlahović-Palčevski V
Int J Pharm Pract; 2018 Apr; 26(2):156-164. PubMed ID: 28665037
[TBL] [Abstract][Full Text] [Related]
2. Potentially inappropriate prescribing in elderly outpatients in Croatia.
Popović B; Quadranti NR; Matanović SM; Lisica ID; Ljubotina A; Duliba DP; Vlahović-Palčevski V
Eur J Clin Pharmacol; 2014 Jun; 70(6):737-44. PubMed ID: 24647976
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of possible drug-drug interactions between antiretroviral agents in different age groups in a section of the private health care sector setting in South Africa.
Katende-Kyenda NL; Lubbe MS; Serfontein JH; Truter I
J Clin Pharm Ther; 2008 Aug; 33(4):393-400. PubMed ID: 18613857
[TBL] [Abstract][Full Text] [Related]
4. Identifying high risk medications causing potential drug-drug interactions in outpatients: A prescription database study based on an online surveillance system.
Toivo TM; Mikkola JA; Laine K; Airaksinen M
Res Social Adm Pharm; 2016; 12(4):559-68. PubMed ID: 26459026
[TBL] [Abstract][Full Text] [Related]
5. The relationship between number of drugs and potential drug-drug interactions in the elderly: a study of over 600,000 elderly patients from the Swedish Prescribed Drug Register.
Johnell K; Klarin I
Drug Saf; 2007; 30(10):911-8. PubMed ID: 17867728
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and pattern of potential drug-drug interactions among chronic kidney disease patients in south-western Nigeria.
Olumuyiwa JF; Akinwumi AA; Ademola OA; Oluwole BA; Ibiene EO
Niger Postgrad Med J; 2017; 24(2):88-92. PubMed ID: 28762362
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of drug-drug interactions of antiretroviral agents in the private health care sector in South Africa.
Katende-Kyenda NL; Lubbe MS; Serfontein JH; Truter I
S Afr Med J; 2008 Feb; 98(2):109-13. PubMed ID: 18350204
[TBL] [Abstract][Full Text] [Related]
8. Assessment of potential drug-drug interactions with a prescription claims database.
Malone DC; Hutchins DS; Haupert H; Hansten P; Duncan B; Van Bergen RC; Solomon SL; Lipton RB
Am J Health Syst Pharm; 2005 Oct; 62(19):1983-91. PubMed ID: 16174833
[TBL] [Abstract][Full Text] [Related]
9. Clinically important potential drug-drug interactions in outpatient settings.
Aparasu R; Baer R; Aparasu A
Res Social Adm Pharm; 2007 Dec; 3(4):426-37. PubMed ID: 18082877
[TBL] [Abstract][Full Text] [Related]
10. Assessing patients' information needs regarding drug-drug interactions.
Mutebi A; Warholak TL; Hines LE; Plummer R; Malone DC
J Am Pharm Assoc (2003); 2013; 53(1):39-45. PubMed ID: 23636154
[TBL] [Abstract][Full Text] [Related]
11. Potentially severe drug interactions in elderly outpatients: results of an observational study of an administrative prescription database.
Nobili A; Pasina L; Tettamanti M; Lucca U; Riva E; Marzona I; Monesi L; Cucchiani R; Bortolotti A; Fortino I; Merlino L; Walter Locatelli G; Giuliani G
J Clin Pharm Ther; 2009 Aug; 34(4):377-86. PubMed ID: 19583670
[TBL] [Abstract][Full Text] [Related]
12. Prescribing patterns of non-steroidal anti-inflammatory drugs in chronic kidney disease patients in the South African private sector.
Meuwesen WP; du Plessis JM; Burger JR; Lubbe MS; Cockeran M
Int J Clin Pharm; 2016 Aug; 38(4):863-9. PubMed ID: 27091130
[TBL] [Abstract][Full Text] [Related]
13. Identification of potential drug-drug interactions between antiretroviral drugs from prescriptions in the private health-care sector in South Africa.
Katende-Kyenda NL; Lubbe MS; Serfontein JH; Truter I
Int J STD AIDS; 2012 Mar; 23(3):166-72. PubMed ID: 22581868
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and predictors of potential drug-drug interactions in Regione Emilia-Romagna, Italy.
Gagne JJ; Maio V; Rabinowitz C
J Clin Pharm Ther; 2008 Apr; 33(2):141-51. PubMed ID: 18315779
[TBL] [Abstract][Full Text] [Related]
15. Clinically relevant potential drug-drug interactions among outpatients: A nationwide database study.
Jazbar J; Locatelli I; Horvat N; Kos M
Res Social Adm Pharm; 2018 Jun; 14(6):572-580. PubMed ID: 28716467
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and predictors of potential drug-drug interactions in the elderly: a cross-sectional study in the brazilian primary public health system.
Obreli Neto PR; Nobili A; Marusic S; Pilger D; Guidoni CM; Baldoni Ade O; Cruciol-Souza JM; Da Cruz AN; Gaeti WP; Cuman RK
J Pharm Pharm Sci; 2012; 15(2):344-54. PubMed ID: 22579012
[TBL] [Abstract][Full Text] [Related]
17. Chronic disease list conditions in patients with rheumatoid arthritis in the private healthcare sector of South Africa.
Olivier N; Burger J; Joubert R; Lubbe M; Naudé A; Cockeran M
Rheumatol Int; 2018 May; 38(5):837-844. PubMed ID: 29234875
[TBL] [Abstract][Full Text] [Related]
18. Retrospective drug utilization review: incidence of clinically relevant potential drug-drug interactions in a large ambulatory population.
Peng CC; Glassman PA; Marks IR; Fowler C; Castiglione B; Good CB
J Manag Care Pharm; 2003; 9(6):513-22. PubMed ID: 14664659
[TBL] [Abstract][Full Text] [Related]
19. Clinically important drug-drug interactions in primary care.
Dhabali AA; Awang R; Zyoud SH
J Clin Pharm Ther; 2012 Aug; 37(4):426-30. PubMed ID: 22081958
[TBL] [Abstract][Full Text] [Related]
20. Potential drug-drug interactions in prescriptions to patients over 45 years of age in primary care, southern Brazil.
Teixeira JJ; Crozatti MT; dos Santos CA; Romano-Lieber NS
PLoS One; 2012; 7(10):e47062. PubMed ID: 23071711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
